CVS Health Corp. diskutieren
CVS Health Corp.
WKN: 859034 / Symbol: CVS / Name: CVS Health / Aktie / Lebensmittel- & Medikamentenhandel / Large Cap /
68,99 €
0,20 %
CVS Health Co. (NYSE: CVS) had its price target raised by analysts at Barclays PLC from $73.00 to $82.00. They now have an "overweight" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) had its price target raised by analysts at Royal Bank of Canada from $74.00 to $81.00. They now have an "outperform" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) had its "overweight" rating re-affirmed by analysts at Wells Fargo & Company.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) had its price target raised by analysts at Truist Financial Co. from $82.00 to $84.00. They now have a "buy" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) had its price target lowered by analysts at Barclays PLC from $82.00 to $79.00. They now have an "overweight" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Corporation (NYSE: CVS) had its price target raised by analysts at Jefferies Financial Group Inc. from $74.00 to $80.00. They now have a "buy" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Corporation (NYSE: CVS) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $82.00 price target on the stock, up previously from $71.00.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $78.00 price target on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its price target raised by analysts at Wolfe Research from $80.00 to $85.00. They now have an "outperform" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its price target raised by analysts at Mizuho from $76.00 to $88.00. They now have an "outperform" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) was given a new $89.00 price target on by analysts at Morgan Stanley. They now have an "overweight" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its price target raised by analysts at Leerink Partners from $86.00 to $95.00. They now have an "outperform" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) was given a new $96.00 price target on by analysts at UBS Group AG. They now have a "buy" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its price target raised by analysts at Cantor Fitzgerald from $78.00 to $95.00. They now have an "overweight" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its price target raised by analysts at Royal Bank Of Canada from $81.00 to $93.00. They now have an "outperform" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its price target raised by analysts at Evercore ISI from $85.00 to $95.00. They now have an "outperform" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its price target raised by analysts at TD Cowen from $99.00 to $100.00. They now have a "buy" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its price target raised by analysts at Argus from $80.00 to $91.00. They now have a "buy" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health (NYSE:CVS) had its price target lowered by analysts at Wells Fargo & Company from $103.00 to $102.00. They now have an "overweight" rating on the stock.
Ratings data for CVS provided by MarketBeat
Neueste Beiträge
Citigroup_Inc_ in Northrop Grumman Corp. diskutieren